Updated on 2025/07/01

写真a

 
Tokura Taichiro
 
Affiliation
Nippon Medical School Hospital, Department of Hematology, Assistant Professor
Title
Assistant Professor
External link

Degree

  • Master's Degree ( University of Massachusetts )

Education

  • University of Massachusetts   Master’s Degree

    2022.4 - 2024.3

    　 More details

    Country： United States

    researchmap

  • Nippon Medical School   Bachelor of Medicine

    2011.4 - 2017.3

    　 More details

  • Nippon Medical School   Postgraduate School   Hematology

    2022.4

    　 More details

Research History

  • Tokyo Metropolitan Tama-Hokubu Medical Center   Hematology

    2024.4

    　 More details

  • Yokohama Minami Kyosai Hospital   Hematology

    2022.10 - 2024.3

    　 More details

  • Nippon Medical School Hospital   Hematology   Assistant Professor

    2022.4 - 2022.9

    　 More details

  • Nippon Medical School Hospital   Hematology

    2021.10 - 2022.3

    　 More details

  • Yokohama Minami Kyosai Hospital   Hematology

    2020.10 - 2021.9

    　 More details

  • Nippon Medical School Hospital   Hematology

    2019.4 - 2020.9

    　 More details

  • Nippon Medical School Hospital   Resident

    2017.4 - 2019.3

    　 More details

  • Los Angeles General Medical Center   Infectious Diseases   Elective

    2016.5

    　 More details

    Country：United States

    researchmap

  • Los Angeles General Medical Center   CCU+Cardiology   Elective

    2016.4

    　 More details

    Country：United States

    researchmap

  • NIH (National Institutes of Health)   NHLBI (National Heart, Lung and Blood Institute), Hematology   Research Assistant

    2013.7 - 2013.9

    　 More details

    Country：United States

    researchmap

▼display all

Papers

  • Disseminated fusariosis successfully treated with empirical liposomal amphotericin B and voriconazole combination followed by ocular therapy in an allogenic hematopoietic stem cell transplant recipient.

    Yuya Kishida, Masahiro Sakaguchi, Tomoyuki Kunishige, Atsushi Takeyoshi, Taichiro Tokura, Kazuki Inai, Ryosuke Kinoshita, Toshio Ibaraki, Satoshi Yamanaka, Toshio Asayama, Shunsuke Yui, Satoshi Wakita, Hiroki Yamaguchi

    Internal medicine 2025 Apr 12.   2025.4

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    We report the case of a 61-year-old man with chronic myelomonocytic leukemia, who underwent unrelated peripheral blood stem cell transplantation. Fusariosis was suspected prior to identification of the fungal species, and voriconazole and liposomal amphotericin B combination therapy were administered. The patient developed fusarium-related endophthalmitis, accompanied by eye pain. Despite vitrectomy, the endophthalmitis was poorly controlled, and the left eye was enucleated. No recurrence of fusariosis was observed until death following multiple-organ failure due to steroid-resistant graft-versus-host disease.

    DOI： 10.2169/internalmedicine.4657-24

    PubMed

    researchmap

  • Safety and efficacy of high-dose cytarabine MEAM therapy and other treatments for auto-peripheral blood stem cell transplantation: A retrospective comparative study. International journal

    Shunsuke Yui, Satoshi Wakita, Yasunobu Nagata, Yasuko Kuribayashi, Toshio Asayama, Yusuke Fujiwara, Masahiro Sakaguchi, Satoshi Yamanaka, Atsushi Marumo, Ikuko Omori, Ryosuke Kinoshita, Daishi Onai, Mika Sunakawa, Yuta Kaito, Kazuki Inai, Taichiro Tokura, Atsushi Takeyoshi, Shunichi Yasuda, Shunsuke Honma, Kazutaka Nakayama, Tsuneaki Hirakawa, Kunihito Arai, Tomoaki Kitano, Muneo Okamoto, Koiti Inokuchi, Hiroki Yamaguchi

    Asia-Pacific journal of clinical oncology   19 ( 1 )   136 - 148   2023.2

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    AIM: The MEAM regimen consisting of ranimustine (MCNU), etoposide (ETP), cytarabine (Ara-C), and melphalan (MEL) is widely used before auto-peripheral blood stem cell transplantation (auto-PBSCT) for malignant lymphoma in Japan. The MEAM regimen generally consists of 200-400 mg/m2 for 4 days, but we decided to increase the dosage of Ara-C from the standard to 2 g/m2 for 2 days with the aim of increasing drug transferability to the central nervous system. We evaluate the safety and therapeutic efficacy of high-dose Ara-C MEAM therapy. METHODS: The high-dose Ara-C MEAM protocol consisted of MCNU 300 mg/m2 on day -7, ETP 200 mg/m2 on days -6, -5, -4, -3 and Ara-C 2 g/m2 on day -4 -3, and MEL 140 mg/m2 on day -2. We retrospectively analyzed 37 cases of malignant lymphoma at our institution between May 2014 and July 2020. RESULTS: All patients got engraftment and there were no cases of treatment-related mortality. In all cases, the 3-year overall survival (OS) and progression-free survival (PFS) after transplantation were 80.6% and 65.7%, respectively. Twenty-one cases of diffuse large B-cell lymphoma recurrence, for which there is proven usefulness of auto-PBSCT, showed good results after transplantation, with the 3-year OS and PFS after transplantation being 100% and 74.3%, respectively. CONCLUSION: The safety and efficacy of high-dose Ara-C MEAM therapy were demonstrated, but the expected therapeutic effect on central nervous system lesions could not be fully evaluated owing to the small number of cases.

    DOI： 10.1111/ajco.13780

    PubMed

    researchmap

  • An advanced case of gastric histiocytic sarcoma treated with chemotherapy and gastrectomy: a case report and review of literature.

    Ryu Matsunaga, Yoshikazu Kanazawa, Kunihiko Matsuno, Daisuke Kakinuma, Taichiro Tokura, Atsushi Marumo, Shunsuke Yui, Fumihiko Ando, Yuka Masuda, Nobutoshi Hagiwara, Tsutomu Nomura, Shunji Kato, Toshiro Yoshiyuki, Yukako Domoto, Takashi Sakatani, Ryuji Ohashi, Koiti Inokuchi, Hiroshi Yoshida

    Clinical journal of gastroenterology   14 ( 4 )   1053 - 1059   2021.8

    　More details

    Language：English   Publisher：シュプリンガー・ジャパン(株)  

    Histiocytic sarcoma is a relatively new disease category and the gastrointestinal origin is sporadic. We report a case of a 74-year-old woman who underwent chemotherapy and proximal gastrectomy for extremely rare, advanced gastric histiocytic sarcoma. The resected specimen was subjected to numerous immunostainings to meet the diagnostic criteria of histiocytic sarcoma and was positive for the histiocyte markers' cluster of differentiation 68 and lysozyme. The markers of Langerhans cells, follicular dendritic cells, and myelocyte were all negative. Six reports of surgical resection of histiocytic sarcoma originating in the stomach exist, including our case. We reviewed the clinical course and the histological and immunohistochemical diagnostic features of surgically resected gastric histiocytic sarcoma.

    DOI： 10.1007/s12328-021-01438-y

    PubMed

    researchmap

    Other Link： https://search.jamas.or.jp/default/link?pub_year=2021&ichushi_jid=J05903&link_issn=&doc_id=20210810190021&doc_link_id=10.1007%2Fs12328-021-01438-y&url=https%3A%2F%2Fdoi.org%2F10.1007%2Fs12328-021-01438-y&type=Crossref&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00002_2.gif

  • Importance of prognostic stratification via gene mutation analysis in elderly patients with acute myelogenous leukemia. International journal

    Yusuke Fujiwara, Hiroki Yamaguchi, Shunsuke Yui, Taichiro Tokura, Kazuki Inai, Daishi Onai, Ikuko Omori, Atsushi Marumo, Satoshi Yamanaka, Masahiro Sakaguchi, Kazuki Terada, Shun Nakagome, Kunihito Arai, Tomoaki Kitano, Masahiro Okabe, Muneo Okamoto, Hayato Tamai, Kazutaka Nakayama, Kenji Tajika, Satoshi Wakita, Koiti Inokuchi

    International journal of laboratory hematology   41 ( 4 )   461 - 471   2019.8

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    INTRODUCTION: Acute myelogenous leukemia (AML) in elderly patients is associated with an increased incidence of complications and treatment-related toxicity because of the frequency of comorbid disease and age-related deterioration in organ function. Despite advances in AML treatment in recent years, elderly patients have experienced limited benefit, and their outcomes remain poor. This study aimed to perform a comprehensive gene mutation analysis in elderly AML patients and identify gene mutations that could serve as prognostic factors. METHODS: An analysis of gene mutations was performed for 281 AML patients, including 98 elderly patients aged 65 years or above. RESULTS: Compared to younger AML patients, elderly patients showed a higher frequency of the following gene mutations: TP53 (P = 0.026), PTPN11 (P = 0.006), RUNX1 (P = 0.024), TET2 (P = 0.002), and ASXL1 (P = 0.023). The complete remission rate was significantly lower in DNMT3A mutation-positive cases (4.26%, P = 0.011) and TP53 mutation-positive cases (2.13%, P = 0.031) than in negative cases. The overall survival rate was significantly poorer in cases with FLT3-ITD (P = 0.003), DNMT3A (P = 0.033), or TP53 mutation (P < 0.001). Conversely, cases with PTPN11 mutation (P = 0.014) had a significantly more favorable prognosis. In multivariate analysis, FLT3-ITD (P = 0.011) and TP53 mutation positivity (P = 0.002) were independent poor prognostic factors, as were a performance status of 3 or above (P < 0.001) and poor cytogenetic prognosis (P = 0.001). In contrast, PTPN11 mutation positivity (P = 0.023) was an independent favorable prognosis factor. CONCLUSION: Analysis of gene mutations in elderly AML patients is very important, not only for establishing prognosis, but also for introducing appropriate molecular-targeted treatments.

    DOI： 10.1111/ijlh.13025

    PubMed

    researchmap

  • Usefulness of BCOR gene mutation as a prognostic factor in acute myeloid leukemia with intermediate cytogenetic prognosis. International journal

    Kazuki Terada, Hiroki Yamaguchi, Toshimitsu Ueki, Kensuke Usuki, Yutaka Kobayashi, Kenji Tajika, Seiji Gomi, Saiko Kurosawa, Riho Saito, Yutaka Furuta, Keiki Miyadera, Taichiro Tokura, Atsushi Marumo, Ikuko Omori, Masahiro Sakaguchi, Yusuke Fujiwara, Shunsuke Yui, Takeshi Ryotokuji, Kunihito Arai, Tomoaki Kitano, Satoshi Wakita, Takahiro Fukuda, Koiti Inokuchi

    Genes, chromosomes & cancer   57 ( 8 )   401 - 408   2018.8

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    BCOR gene is a transcription regulatory factor that plays an essential role in normal hematopoiesis. The wider introduction of next-generation sequencing technology has led to reports in recent years of mutations in the BCOR gene in acute myeloid leukemia (AML), but the related clinical characteristics and prognosis are not sufficiently understood. We investigated the clinical characteristics and prognosis of 377 de novo AML cases with BCOR or BCORL1 mutation. BCOR or BCORL1 gene mutations were found in 28 cases (7.4%). Among cases aged 65 years or below that were also FLT3-ITD-negative and in the intermediate cytogenetic prognosis group, BCOR or BCORL1 gene mutations were observed in 11% of cases (12 of 111 cases), and this group had significantly lower 5-year overall survival (OS) (13.6% vs. 55.0%, P = 0.0021) and relapse-free survival (RFS) (14.3% vs. 44.5%, P = 0.0168) compared to cases without BCOR or BCORL1 gene mutations. Multivariate analysis demonstrated that BCOR mutations were an independent unfavorable prognostic factor (P = 0.0038, P = 0.0463) for both OS and RFS. In cases of AML that are FLT3-ITD-negative, aged 65 years or below, and in the intermediate cytogenetic prognosis group, which are considered to have relatively favorable prognosis, BCOR gene mutations appear to be an important prognostic factor.

    DOI： 10.1002/gcc.22542

    PubMed

    researchmap

  • Full-length mutation search of the TP53 gene in acute myeloid leukemia has increased significance as a prognostic factor. International journal

    Kazuki Terada, Hiroki Yamaguchi, Toshimitsu Ueki, Kensuke Usuki, Yutaka Kobayashi, Kenji Tajika, Seiji Gomi, Saiko Kurosawa, Keiki Miyadera, Taichiro Tokura, Ikuko Omori, Atushi Marumo, Yusuke Fujiwara, Shunsuke Yui, Takeshi Ryotokuji, Yoshiki Osaki, Kunihito Arai, Tomoaki Kitano, Fumiko Kosaka, Satoshi Wakita, Hayato Tamai, Takahiro Fukuda, Koiti Inokuchi

    Annals of hematology   97 ( 1 )   51 - 61   2018.1

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    TP53 gene abnormality has been reported to be an unfavorable prognostic factor in acute myeloid leukemia (AML). However, almost all studies of TP53 gene abnormality so far have been limited to mutation searches in the DNA binding domain. As there have been few reports examining both mutation and deletion over the full-length of the TP53 gene, the clinical characteristics of TP53 gene abnormality have not yet been clearly established. In this study, TP53 gene mutation was observed in 7.3% of the total 412 de novo AML cases (33 mutations in 30 cases), with mutation outside the DNA binding domain in eight cases (27%). TP53 gene deletion was observed in 3.1% of 358 cases. All cases had monoallelic deletion with TP53 gene mutation on the opposite allele. Multivariate analysis demonstrated that TP53 gene mutation in the DNA binding domain and outside the DNA binding domain was an independent poor prognostic factor for overall survival and relapse-free survival among the total cohort and it is also an unfavorable prognostic factor in FLT3-ITD-negative AML cases aged 70 years or below with intermediate cytogenetic prognosis. In stratified treatment, full-length search for TP53 gene mutation is therefore very important.

    DOI： 10.1007/s00277-017-3143-2

    PubMed

    researchmap

▼display all

Misc.

  • 胸腹水貯留で発症した多発性骨髄腫の一例

    黒崎祥子, 土蔵太一朗, 岸田侑也, 中山一隆

    共済医報   73 ( 1 )   2024

    　More details

  • 胸腹水貯留を契機に診断された多発性骨髄腫の1例

    黒崎祥子, 土蔵太一朗, 岸田侑也, 中山一隆

    臨床血液   65 ( 4 )   2024

    　More details

  • 左肺全摘後の慢性膿胸から生じた膿胸関連リンパ腫(PAL)に対し,化学放射線療法が奏効した1例

    土蔵太一朗, 岸田侑也, 中山一隆

    臨床血液   65 ( 4 )   2024

    　More details

  • Prophylactic colectomy and hematopoietic stem cell transplantation for myelodysplastic syndrome

    土蔵太一朗, 由井俊輔, 砂川美香, 丸毛淳史, 岡本宗雄, 脇田知志, 山口博樹

    日本造血・免疫細胞療法学会総会プログラム・抄録集   46th   2024

    　More details

  • 昏睡とCushing反射を伴うDLBCL脳内再発にtirabrutinibの簡易懸濁液が奏効した症例

    土蔵太一朗, 岸田侑也, 中山一隆

    臨床血液   65 ( 4 )   2024

    　More details

  • The clinical features and prognostic impact of acute myeloid leukemia with KMT2A gene abnormalities

    TOKURA Taichiro, WAKITA Satoshi, MARUMO Atsushi, MORITA Kaoru, KAKO Shinichi, DOKI Noriko, KANDA Junya, KURODA Junya, MORI Shinichiro, SATAKE Atsushi, USUKI Kensuke, UEKI Toshimitsu, UOSHIMA Nobuhiko, KAWATA Eri, NAKAYAMA Kazutaka, NAGAO Yuhei, SHONO Katsuhiro, SHIBUSAWA Motoharu, KIMURA Shinya, ICHINOHE Tatsuo, MOTOMURA Sayuri, HASHIMOTO Akiko, SATO Eriko, OGATA Masao, ANDO Jun, TASHIRO Haruko, SAKAGUCHI Masahiro, KANDA Yoshinobu, KANDA Yoshinobu, YAMAGUCHI Hiroki

    日本血液学会学術集会抄録(Web)   85th   2023

    　More details

  • Efficacy of clinically significant CMV infection prophylaxis with Letermovir in allo-HSCT

    五島祐樹, 平川経晃, 由井俊輔, 阪口正洋, 朝山敏夫, 山中聡, 茨木利夫, 稲井一貴, 土蔵太一朗, 本間俊佑, 竹吉敦志, 保田駿一, 松本菜々, 丸毛淳史, 木下量介, 永田安伸, 砂川実香, 岸田侑也, 尾内大志, 脇田知志, 山口博樹

    日本造血・免疫細胞療法学会総会プログラム・抄録集   45th   2022

    　More details

  • Successful treatment of central nervous system dysfunction after HLA-haploidentical transplantation

    土蔵太一朗, 由井俊輔, 木下量介, 茨木利夫, 平川経晃, 朝山敏夫, 阪口正洋, 脇田知志, 山口博樹

    日本造血・免疫細胞療法学会総会プログラム・抄録集   45th   2022

    　More details

  • Clinical characteristics of noninfectious lung complications in allogenic stem cell transplantation

    朝山敏夫, 由井俊輔, 脇田知志, 永田安伸, 栗林泰子, 藤原裕介, 阪口正洋, 山中聡, 丸毛淳史, 大森郁子, 木下量介, 砂川実香, 海渡裕太, 尾内大志, 稲井一貴, 土蔵太一朗, 本間俊祐, 竹吉敦志, 保田駿一, 岸田侑也, 岡本宗雄, 山口博樹

    日本造血・免疫細胞療法学会総会プログラム・抄録集   44th   2022

    　More details

  • Outcomes of Transplatation in Patients with Multiple Myeloma in our hospital

    保田駿一, 由井俊輔, 本間俊佑, 竹吉敦志, 土蔵太一朗, 稲井一貴, 尾内大志, 砂川美香, 岸田侑也, 山中聡, 朝山敏夫, 阪口正洋, 藤原裕介, 永田安伸, 大森郁子, 脇田知志, 岡本宗雄, 山口博樹

    日本造血・免疫細胞療法学会総会プログラム・抄録集   44th   2022

    　More details

  • Effect of allogenic HSCT for acute lymphoblastic leukemia

    竹吉敦志, 由井俊輔, 本間俊佑, 保田駿一, 土蔵太一朗, 稲井一貴, 山中聡, 阪口正洋, 永田安伸, 脇田知志, 岡本宗雄, 山口博樹

    日本造血・免疫細胞療法学会総会プログラム・抄録集   44th   2022

    　More details

  • Allogeneic stem cell transplantation for myelodysplastic syndromes in single institution study

    木下量介, 由井俊輔, 保田俊一, 竹吉敦志, 土蔵太一朗, 安達弘人, 岸田侑也, 砂川実香, 尾内大志, 丸毛淳史, 大森郁子, 山中聡, 朝山敏夫, 阪口正洋, 永田安伸, 脇田知志, 岡本宗雄, 山口博樹

    日本造血・免疫細胞療法学会総会プログラム・抄録集   44th   2022

    　More details

  • 好酸球増多を伴う骨髄異形成症候群に劇症型好酸球性心筋症を合併した1剖検例

    竹吉敦志, 脇田知志, 本間俊佑, 保田駿一, 土蔵太一朗, 稲井一貴, 丸毛淳史, 山中聡, 阪口正洋, 永田安伸, 由井俊輔, 岡本宗雄, 山口博樹

    臨床血液   63 ( 5 )   2022

    　More details

  • Results of hematopoietic stem cell transplantation for the elderly at our hospital

    稲井一貴, 由井俊輔, 本間俊佑, 保田駿一, 竹吉敦志, 土蔵太一朗, 砂川実香, 尾内大志, 海渡裕太, 岸田侑也, 木下量介, 丸毛敦史, 大森郁子, 山中聡, 阪口正洋, 藤原裕介, 朝山敏夫, 永田安伸, 脇田知志, 岡本宗雄, 山口博樹

    日本造血・免疫細胞療法学会総会プログラム・抄録集   44th   2022

    　More details

  • A case of plasma cell cellular cheilitis that developed after allogeneic hematopoietic stem cell tra

    本間俊佑, 由井俊輔, 松本菜々, 五島祐樹, 土蔵太一朗, 稲井一貴, 茨木利夫, 朝山敏夫, 山中聡, 阪口正洋, 脇田知志, 山口博樹

    日本造血・免疫細胞療法学会総会プログラム・抄録集   45th   2022

    　More details

  • Successful treatment of central nervous system GVHD after haploidentical stem cell transplantation

    TOKURA Taichiro, KINOSHITA Ryosuke, ASAYAMA Toshio, KANBARA Yasuhiro, UCHIBORI Yusuke, NISHIJIMA Akihiko, KOBAYASHI Takeshi, DOKI Noriko, SAKAGUCHI Masahiro, YUI Shunsuke, WAKITA Satoshi, OKAMOTO Muneo, YAMAGUCHI Hiroki

    日本血液学会学術集会抄録(Web)   84th   2022

    　More details

  • T-lymphoblastic leukemia with central nervous involvement diagnosed with impaired consciousness

    TAKEYOSHI Atsushi, YUI Syunsuke, YASUDA Shunichi, TOKURA Taichiro, INAI Kazuki, MARUMO Atsushi, YAMANAKA Satoshi, SAKAGUCHI Masahiro, NAGATA Yasunobu, WAKITA Satoshi, YAMAGUCHI Hiroki

    日本血液学会学術集会抄録(Web)   84th   2022

    　More details

  • Utility of the diagnosis about bone marrow and gastrointestinal lymphoma lesion using PET-CT

    YASUDA Shunichi, YUI Shunsuke, TAKEYOSHI Atsushi, HOMMA Shunsuke, TOKURA Taichiro, INAI Kazuki, KISHIDA Yuya, KINOSHITA Ryosuke, YAMANAKA Satoshi, ASAYAMA Toshio, SAKAGUCHI Masahiro, NAGATA Yasunobu, WAKITA Satoshi, OKAMOTO Muneo, YAMAGUCHI Hiroki

    日本血液学会学術集会抄録(Web)   84th   2022

    　More details

  • A case of systemic AL amyloidosis identified by autopsy with suspected epicardial amyloid deposits on echocardiography

    千葉美緒, 立石遼, 土蔵太一朗, 三須彬生, 小嶋結, 西郡修平, 中山一隆, 藤井洋之

    超音波医学   49 ( 1 )   2022

    　More details

  • HDC/ASCT for mantle cell lymphoma in single institution study

    KINOSHITA Ryosuke, YUI Shunsuke, WAKITA Satoshi, ASAYAMA Toshio, SAKAGUCHI Masahiro, TOKURA Taichiro, TAKEYOSHI Atsushi, INAI Kazuki, KISHIDA Yuya, IBARAKI Toshio, YAMANAKA Satoshi, YAMAGUCHI Hiroki

    日本血液学会学術集会抄録(Web)   84th   2022

    　More details

  • A case of immune thrombocytopenia triggered by mRNA-1273 vaccination

    INAI Kazuki, SAKAGUCHI Masahiro, KISHIDA Yuya, TAKEYOSHI Atsushi, TOKURA Taichiro, SUNAKAWA Mika, KINOSHITA Ryosuke, IBARAKI Toshio, YAMANAKA Satoshi, ASAYAMA Toshio, YUI Shunsuke, WAKITA Satoshi, YAMAGUCHI Hiroki

    日本血液学会学術集会抄録(Web)   84th   2022

    　More details

  • Efficacy of myeloma therapy before and after the era of monoclonal antibodies

    田近賢二, 土蔵太一朗, 加藤せい子, 中山一隆

    日本血液学会学術集会抄録(Web)   83rd   2021

    　More details

  • Examination of the usefulness of translocation-type gene abnormality detection using i-densy IS-5320

    由井俊輔, 岡本宗雄, 脇田知志, 永田安伸, 栗林泰子, 朝山敏夫, 藤原裕介, 阪口正洋, 山中聡, 丸毛淳史, 大森郁子, 木下量介, 尾内大志, 砂川実香, 海渡裕太, 稲井一貴, 土蔵太一朗, 竹吉敦志, 保田駿一, 本間俊佑, 荒井邦仁, 北野智章, 宮田美保, 土岐典子, 諫田淳也, 平井光春, 木寺一喜, 猪口孝一, 山口博樹

    日本血液学会学術集会抄録(Web)   83rd   2021

    　More details

  • Clinical characteristics of noninfectious lung complication in allogenic stem cell transplantation

    朝山敏夫, 由井俊輔, 脇田知志, 永田安伸, 栗林泰子, 藤原裕介, 阪口正洋, 山中聡, 丸毛淳史, 大森郁子, 木下量介, 砂川実香, 海渡裕太, 尾内大志, 稲井一貴, 土蔵太一朗, 本間俊祐, 竹吉敦志, 保田駿一, 岡本宗雄, 猪口孝一, 山口博樹

    日本血液学会学術集会抄録(Web)   83rd   2021

    　More details

  • 予後不良因子を複数伴った化学療法抵抗性のCD19陽性AMLに対して臍帯血移植が奏効した1例

    山口玲, 阪口正洋, 稲井一貴, 土蔵太一朗, 竹吉敦志, 保田駿一, 本間俊佑, 尾内大志, 砂川実香, 丸毛淳史, 山中聡, 朝山敏夫, 永田安伸, 由井俊輔, 脇田知志, 岡本宗雄, 山口博樹, 猪口孝一

    臨床血液   62 ( 10 )   2021

    　More details

  • A case report of differential syndrome induced by gilteritinib in FLT3-ITD positive AML

    竹吉敦志, 丸毛淳史, 土蔵太一朗, 尾内大志, 阪口正洋, 由井俊輔, 永田安伸, 朝山敏夫, 脇田知志, 猪口孝一, 山口博樹

    日本血液学会学術集会抄録(Web)   83rd   2021

    　More details

  • 造血幹細胞移植患者のアスペルギルス感染症に対するL-AMB投与中に生じた腎機能障害の原因がBKウイルス腎症であった1例

    土蔵太一朗

    日本感染症学会東日本地方会学術集会・日本化学療法学会東日本支部総会合同学会プログラム・抄録集   70th-68th   2021

    　More details

  • Association between tongue wetness and oral mucositis in hematopoietic stem cell transplantation

    高澤理奈, 原田枝里, 由井俊輔, 斉藤芳徳, 外園卓也, 永田安伸, 保田駿一, 竹吉敦志, 本間俊佑, 土蔵太一朗, 尾内大志, 脇田知志, 服部薫, 岡本宗雄, 久野彰子, 山口博樹, 猪口孝一

    日本造血細胞移植学会総会プログラム・抄録集   43rd   2021

    　More details

  • 急性リンパ性白血病(ALL)患者の意識障害の原因が敗血症を契機に発症した粘液水腫性昏睡と診断し,集学的治療によって治癒に至った1例

    土蔵太一朗, 砂川美香, 岡本宗雄, 山口博樹, 猪口孝一

    日本集中治療医学会関東甲信越支部学術集会プログラム・抄録集(Web)   4th   2020

    　More details

  • 無治療で自然軽快したびまん性大細胞型B細胞リンパ腫の一例

    尾内大志, 由井俊輔, 土蔵太一朗, 阪口正洋, 脇田知志, 岡本宗雄, 山口博樹, 猪口孝一

    日本血液学会学術集会抄録(Web)   82nd   2020

    　More details

  • 大量シタラビンでのMEAM療法を前処置とした自家末梢血幹細胞移植の成績

    由井俊輔, 山口博樹, 土蔵太一朗, 稲井一貴, 尾内大志, 砂川実香, 木下量介, 大森郁子, 丸毛淳史, 山中聡, 朝山敏夫, 藤原裕介, 栗林泰子, 脇田知志, 岡本宗雄, 猪口孝一

    日本血液学会学術集会抄録(Web)   82nd   2020

    　More details

  • Association between tongue wetness and oral mucositis in patients undergoing hematopoietic stem cell transplantation

    高澤理奈, 原田枝里, 服部馨, 久野彰子, 斎藤芳徳, 外園卓也, 阪口正洋, 土蔵太一朗, 稲井一貴, 砂川実香, 尾内大志, 山中聡, 藤原祐介, 脇田知志, 由井俊輔, 山口文子, 岡本宗雄, 山口博樹, 猪口孝一

    日本造血細胞移植学会総会プログラム・抄録集   42nd   2020

    　More details

  • 高カルシウム血症から洞停止を起こした骨融解型の濾胞性リンパ腫の1例

    土蔵太一朗, 由井俊輔, 砂川実香, 岡本宗雄, 山口博樹, 猪口孝一

    臨床血液   61 ( 8 )   2020

    　More details

  • Taste disorders in patients undergoing hematopoietic stem cell transplantation

    斎藤芳徳, 外薗卓也, 由井俊輔, 服部馨, 高澤理奈, 原田枝里, 土蔵太一朗, 脇田知志, 藤原裕介, 山中聡, 尾内大志, 砂川実香, 稲井一貴, 阪口正洋, 山口文子, 岡本宗雄, 久野彰子, 山口博樹, 猪口孝一

    日本造血細胞移植学会総会プログラム・抄録集   42nd   2020

    　More details

  • Stenotrophomonas maltophilia肺炎から心外膜炎,心タンポナーデを来たした1例

    土蔵太一朗

    日本感染症学会東日本地方会学術集会・日本化学療法学会東日本支部総会合同学会プログラム・抄録集   69th-67th   2020

    　More details

  • Clinical features and prognostic impact of AML with the cohesin complex genes mutations

    KUBOYAMA Marika, DATE Kenta, SAKAGUCHI Masahiro, UEKI Toshimitsu, USUKI Kensuke, KOBAYASHI Yutaka, TAJIKA Kenji, GOMI Seiji, KUROSAWA Saiko, TOKURA Taichiro, INAI Kazuki, ONAI Daishi, MARUMO Atsushi, OMORI Ikuko, YAMANAKA Satoshi, FUJIWARA Yusuke, YUI Shunsuke, WAKITA Satoshi, OKAMOTO Muneo, MIYATA Miho, ARAI Kunihito, KITANO Tomoaki, TERADA Kazuki, FUKUDA Takahiro, YAMAGUCHI Hiroki, INOKUCHI Koichi

    日本血液学会学術集会抄録(Web)   81st   2019

    　More details

  • ホジキンリンパ腫(HL)発症後に特発性血小板減少性紫斑病(ITP)を合併した1例

    土蔵太一朗, 中山一隆, 尾内大志, 朝山敏夫, 由井俊輔, 岡本宗雄, 山口博樹, 猪口孝一

    臨床血液   59 ( 5 )   2018

    　More details

  • The clinical features and prognostic impact of acute myeloid leukemia with BCOR/BCORL1 gene mutation

    SAITO Riho, YAMAGUCHI Hiroki, UEKI Toshimitsu, USUKI Kensuke, KOBAYASHI Yutaka, TAJIKA Kenji, GOMI Seiji, KUROSAWA Saiko, FURUTA Yutaka, TOKURA Taichiro, MIYADERA Keiki, YUI Shunsuke, FUKUNAGA Keiko, RYOTOKUJI Takeshi, OSAKI Yoshiki, ARAI Kunihito, KITANO Tomoaki, KOSAKA Fumiko, TERADA Kazuki, FUKUDA Takahiro, INOKUCHI Koiti

    臨床血液   57 ( 9 )   2016

    　More details

  • The clinical features and prognostic impact of acute myeloid leukemia with NOCTH1/2 gene mutation

    FURUTA Yutaka, YAMAGUCHI Hiroki, UEKI Toshimitsu, USUKI Kensuke, KOBAYASHI Yutaka, TAJIKA Kenji, GOMI Seiji, KUROSAWA Saiko, SAITO Riho, TOKURA Taichiro, MIYADERA Keiki, TERADA Kazuki, FUKUNAGA Keiko, RYOTOKUJI Takeshi, OSAKI Yoshiki, ARAI Kunihito, KITANO Tomoaki, KOSAKA Fumiko, FUKUDA Takahiro, INOKUCHI Koiti

    臨床血液   57 ( 9 )   2016

    　More details

  • The clinical features and prognostic impact of acute myeloid leukemia with MLL gene aberrations

    TOKURA Taichiro, YAMAGUCHI Hiroki, UEKI Toshimitsu, USUKI Kensuke, KOBAYASHI Yutaka, TAJIKA Kenji, GOMI Seiji, KUROSAWA Saiko, MIYADERA Keiki, WATANABE Makoto, KOBAYASHI Anna, FUJIWARA Yusuke, YUI Shunsuke, FUKUNAGA Keiko, WAKAITA Satoshi, HIRAKAWA Tuneaki, RYOTOKUJI Takeshi, ARAI Kunihito, KITANO Tomoaki, KOSAKA Fumiko, TAMAI Hayato, FUKUDA Takahiro, INOKUCHI Koiti

    臨床血液   56 ( 9 )   2015

    　More details

  • Complex genetic abnormalities are important prognostic factors for acute myeloid leukemia

    WAKITA Satoshi, YAMAGUCHI Hiroki, UEKI Toshimatsu, USUKI Kensuke, KOBAYASHI Yutaka, TAJIKA Kenji, GOMI Seiji, KUROSAWA Saiko, TOKURA Taichiro, WATANABE Makoto, KOBAYASHI Anna, FUJIWARA Yusuke, YUI Shunsuke, FUKUNAGA Keiko, HIRAKAWA Tuneaki, RYOTOKUJI Takeshi, TAMAI Hayato, ARAI Kunihito, KITANO Tomoaki, KOSAKA Fumiko, FUKUDA Takahiro, INOKUCHI Koiti

    臨床血液   56 ( 9 )   2015

    　More details

  • The clinical and prognostic features of de novo AML with epigenetics regulative gene mutation

    RYOTOKUJI Takeshi, YAMAGUCHI Hiroki, UEKI Toshimitsu, USUKI Kensuke, KOBAYASHI Yutaka, TAJIKA Kenji, GOMI Seiji, KUROSAWA Saiko, TOKURA Taichiro, MIYADERA Keiki, WATANABE Makoto, KOBAYASHI Anna, FUJIWARA Yusuke, YUI Shunsuke, FUKUNAGA Keiko, WAKITA Satoshi, HIRAKAWA Tsuneaki, ARAI Kunihito, KITANO Tomoaki, KOSAKA Fumiko, TAMAI Hayato, FUKUDA Takahiro, INOKUCHI Koiti

    臨床血液   56 ( 9 )   2015

    　More details

  • The clinical features of acute myeloid leukemia with TP53 mutation

    MIYADERA Keiki, YAMAGUCHI Hiroki, UEKI Toshimitsu, USUKI Kensuke, KOBAYASHI Yutaka, TAJIKA Kenji, GOMI Seiji, KUROSAWA Saiko, TOKURA Taichiro, WATANABE Makoto, KOBAYASHI Anna, FUJIWARA Yusuke, YUI Shunsuke, FUKUNAGA Keiko, WAKITA Satoshi, HIRAKAWA Tuneaki, RYOTOKUJI Takeshi, ARAI Kunihito, KITANO Tomoaki, KOSAKA Fumiko, TAMAI Hayato, FUKUDA Takahiro, INOKUCHI Koiti

    臨床血液   56 ( 9 )   2015

    　More details

▼display all

Presentations

  • A case of successful response to steroid, cyclosporine, and ibrutinib for central nervous system dysfunction following HLA-haploidentical hematopoietic stem cell transplantation

    Taichiro Tokura, Shunsuke Yui, Ryosuke Kinoshita, Toshio Ibaraki, Tsuneaki Hirakawa, Toshio Asayama, Masahiro Sakagushi, Satoshi Wakita, Hiroki Yamagushi

    The 45th Annual Meeting of the Japanese Society for Transplantation and Cellular Therapy  2023.2 

    　More details

  • Successful treatment and diagnosis of myxedema coma secondary to sepsis in a patient with acute lymphoblastic leukemia: A case report

    Taichiro Tokura, Mika Sunakawa, Muneo Okamoto, Hiroki Yamaguchi, Koichi Inokuchi

    The 4th Regional Meeting of The Japanese Society of Intensive Care Medicine  2020.9 

    　More details

  • Hypercalcemia-triggered sinus arrest in a case of osteolytic follicular lymphoma

    Taichiro Tokura, Shunsuke Yui, Mika Sunakawa, Muneo Okamoto, Hiroki Yamaguchi, Koichi Inokuchi

    The 12th Kanto-Koshinetsu Regional Meeting of the Japanese Society of Hematology  2020.3 

    　More details

  • A case of idiopathic thrombocytopenic purpura (ITP) occurring after the onset of Hodgkin's lymphoma (HL)

    Taichiro Tokura, Kazutaka Nakayama, Daishi Onai, Toshio Asayama, Syunsuke Yui, Muneo Okamoto, Hiroki Yamagushi, Koishi Inokuchi

    The 8th Kanto-Koshinetsu Regional Meeting of the Japanese Society of Hematology  2018.3 

    　More details

  • The clinical features and prognostic impact of acute myeloid leukemia with MLL gene aberrations including MLL-PTD, MLL translocation and MLL mutations

    Taichiro Tokura, Hiroki Yamaguchi, Toshimitsu Ueki, Kensuke Usuki, Yutaka Kobayashi, Kenji Tajika, Gomi Seiji, Keiki Miyadera, Makoto Watanabe, Anna Kobayashi, Ikuko Omori, Yusuke Fujiwara, Fukunaga Keiko, Satoshi Wakita, Tsuneaki Hirakawa, Takeshi Ryotokuji, Kunihito Arai, Tomoaki Kitano, Fumiko Kosaka, Hayato Tamai, Koiti Inokuchi

    The 77th Annual Meeting of the Japanese Society of Hematology  2015.10 

    　More details

  • Successful management of central nervous system GVHD post HLA-haploidentical hematopoietic stem cell transplantation with steroid, cyclosporine, and MSC products

    Taichiro Tokura, Ryosuke Kinoshita, Toshio Asayama, Yasuhiro Kanbara, Yusuke Uchibori, Akihiko Nishijima, Takeshi Kobayashi, Noriko Doki, Yuko Nishio, Masahiro Sakaguchi, Shunsuke Yui, Satoshi Wakita, Muneo Okamoto, Hiroki Yamaguchi

    The 84th Annual Meeting of the Japanese Society of Hematology  2022.10 

    　More details

  • Renal dysfunction caused by BK virus nephropathy emerged in a patient administered with L-AMB for Aspergillus infection following hematopoietic stem cell transplantation: A case report

    Taichiro Tokura

    The 70th Annual Meeting of the Eastern Japan Branch of the Japanese Association for Infectious Diseases/The 69th Annual Meeting of the Eastern Japan Branch of the Japanese Society of Chemotherapy  2021.10 

    　More details

  • A case of Stenotrophomonas maltophilia pneumonia progressed to pericarditis and cardiac tamponade

    Taichiro Tokura

    The 69th Annual Meeting of the Eastern Japan Branch of the Japanese Association for Infectious Diseases/The 67th Annual Meeting of the Eastern Japan Branch of the Japanese Society of Chemotherapy  2020.10 

    　More details

  • The clinical features and prognostic impact of acute myeloid leukemia with KMT2A gene abnormalities

    Taichiro Tokura, Satoshi Wakita, Atsushi Marumo, Kaoru Morita, Shinichi Kako, Noriko Doki, Junya Kanda, Junya Kuroda, Shinichiro Mori, Atsushi Satake, Kensuke Usuki, Toshimitsu Ueki, Nobuhiko Uoshima, Eri Kawata, Kazutaka Nakayama, Yuhei Nagao, Katsuhiro Shono, Motoharu Shibusawa, Shinya Kimura, Tatsuo Ichinohe, Sayuri Motomura, Akiko Hashimoto, Eriko Sato, Masao Ogata, Jun Ando, Haruko Tashiro, Masahiro Sakaguchi, Yoshinobu Kanda, Hiroki Yamaguchi

    The 85th Annual Meeting of the Japanese Society of Hematology  2023.10 

    　More details

  • Clinical outcomes of R-THP-COP as first-line chemotherapy in patients with DLBCL aged 80 years and older

    Taichiro Tokura, Satoshi Wakita, Shunsuke Yui, Muneo Okamoto, Hiroki Yamaguchi, Koichi Inokuchi

    The 52th Meeting of the Society for Geriatric Hematology  2019.7 

    　More details

  • A successful case of chemoradiotherapy for pyothorax-associated lymphoma (PAL) arising from chronic empyema after left total pneumonectomy

    Taichiro Tokura, Yuya Kishida, Kazutaka Nakayama

    The 20th Kanto-Koshinetsu Regional Meeting of the Japanese Society of Hematology  2024.3 

    　More details

  • Myelodysplastic syndrome treated with hematopoietic stem cell transplantation after prophylactic colectomy to prevent recurrence of repeated diverticulitis

    Taichiro Tokura, Shunsuke Yui, Mika Sunakawa, Atsushi Marumo, Muneo Okamoto, Satoshi Wakita, Hiroki Yamagushi

    The 46th Annual Meeting of the Japanese Society for Transplantation and Cellular Therapy  2024.3 

    　More details

  • A successful case of tirabrutinib suspension for DLBCL brain relapse with coma and Cushing reflex

    Taichiro Tokura, Yuya Kishida, Kazutaka Nakayama

    The 20th Kanto-Koshinetsu Regional Meeting of the Japanese Society of Hematology  2024.3 

    　More details

  • A case of septic cardiomyopathy rapidly developed from Salmonella colitis during maintenance therapy for multiple myeloma, requiring intensive treatment with IABP

    Taichiro Tokura, Yuya Kishida, Kazutaka Nakayama

    The 98th Annual Meeting of the Japanese Association for Infectious Diseases/The 72nd Annual Meeting of the Japanese Society of Chemotherapy  2024.6 

    　More details

  • Trousseau syndrome presenting with dysarthria and right upper limb paralysis during complete remission of follicular lymphoma: a case successfully treated with heparin and DOAC

    Taichiro Tokura, Youhei Imai, Reina Saga, Hiroko Hidai, Hideki Akiyama, Yoshiro Murai, Sayuri Motomura

    The 47th Congress of the Japanese Society on Thrombosis and Hemostasis  2025.6 

    　More details

▼display all

Awards

  • Best Poster Award

    2023.10   The 85th Annual Meeting of the Japanese Society of Hematology   The clinical features and prognostic impact of acute myeloid leukemia with KMT2A gene abnormalities

    Taichiro Tokura, Satoshi Wakita, Atsushi Marumo, Kaoru Morita, Shinichi Kako, Noriko Doki, Junya Kanda, Junya Kuroda, Shinichiro Mori, Atsushi Satake, Kensuke Usuki, Toshimitsu Ueki, Nobuhiko Uoshima, Eri Kawata, Kazutaka Nakayama, Yuhei Nagao, Katsuhiro Shono, Motoharu Shibusawa, Shinya Kimura, Tatsuo Ichinohe, Sayuri Motomura, Akiko Hashimoto, Eriko Sato, Masao Ogata, Jun Ando, Haruko Tashiro, Masahiro Sakaguchi, Yoshinobu Kanda, Hiroki Yamaguchi

    　More details

  • Young Best Presentation Award

    2020.9   The 4th Regional Meeting of The Japanese Society of Intensive Care Medicine   Successful treatment and diagnosis of myxedema coma secondary to sepsis in a patient with acute lymphoblastic leukemia: A case report

    Taichiro Tokura, Mika Sunakawa, Muneo Okamoto, Hiroki Yamaguchi, Koichi Inokuchi

    　More details

    Award type：Award from Japanese society, conference, symposium, etc. 

    researchmap

  • Special Award

    2019.7   The 52th Meeting of the Society for Geriatric Hematology   Clinical outcomes of R-THP-COP as first-line chemotherapy in patients with DLBCL aged 80 years and older

    Taichiro Tokura, Satoshi Wakita, Shunsuke Yui, Muneo Okamoto, Hiroki Yamaguchi, Koichi Inokuchi

    　More details

  • Best Research Award

    2017.3   Nippon Medical School  

    Taichiro Tokura

    　More details